Heron Therapeutics | HRTX - الدائنين التجاريين





الدائنين التجاريين تغيير تاريخ
ALKERMES USD 142.86M 40.5M 2026-06
Alnylam Pharmaceuticals USD 108.02M 18.61M 2026-06
Amarin USD 18.8M 29.36M 2026-06
ANI Pharmaceuticals USD 73.83M 4.14M 2026-06
Anika Therapeutics USD 6.24M 103K 2026-06
Arrowhead Research USD 27.78M 2.97M 2026-06
Eisai JPY 87.53B 11.64B 2026-06
Emergent BioSolutions USD 112.2M 500K 2023-12
GlaxoSmithKline GBP 14.34B 7M 2026-06
Heron Therapeutics USD 11.64M 2.67M 2026-06
Insmed USD 74.55M 1.18M 2026-06
Ligand Pharmaceuticals USD 9.4M 27.7M 2026-06
Merck USD 3.83B 36M 2026-06
Nektar Therapeutics USD 10.03M 744K 2026-03
Neurocrine Biosciences USD 691.3M 145.8M 2026-03
Omeros USD 8.84M 4.42M 2025-06
Pacira USD 17.51M 3.5M 2026-06
Regeneron Pharmaceuticals USD 1.16B 132.2M 2026-06
Roche Holding CHF 5.54B 237M 2026-06
Sangamo BioSciences USD 10.74M 7.46M 2025-06
Ultragenyx Pharmaceutical USD 39M 3M 2026-06
Veracyte USD 8.02M 1.12M 2026-06
Vertex Pharmaceuticals USD 3.61B 135M 2026-06